Suppr超能文献

血红蛋白、白蛋白、淋巴细胞和血小板评分与糖尿病或糖尿病前期成年人全因死亡率和心血管死亡率的关联:2005 - 2018年美国国家健康与营养检查调查结果

Association of hemoglobin, albumin, lymphocyte, and platelet score with all-cause and cardiovascular mortality in adults with diabetes or prediabetes: Results from NHANES 2005-2018.

作者信息

Zhang Taotao, Liu Peiqian

机构信息

Department of Endocrinology, Fengyang People's Hospital, Fengyang, China.

出版信息

Prev Med Rep. 2025 May 5;54:103101. doi: 10.1016/j.pmedr.2025.103101. eCollection 2025 Jun.

Abstract

OBJECTIVE

The relationship between the hemoglobin, albumin, lymphocyte, and platelet (HALP) score and mortality in patients with diabetes/prediabetes remains uncertain. This study aimed to evaluate linear and non-linear associations between the HALP score and all-cause and cardiovascular mortality in this population and identify potential clinically relevant thresholds.

METHODS

We analyzed data from 19,350 United States adults with diabetes/prediabetes using two linked datasets: the National Health and Nutrition Examination Survey (NHANES, 2005-2018) and mortality records from the National Death Index (NDI), with follow-up through December 31, 2019. Kaplan-Meier survival curves, Cox proportional hazards models, and restricted cubic splines (RCS) were used to evaluate the HALP score and mortality associations.

RESULTS

Kaplan-Meier analysis revealed the highest all-cause mortality in Q1, the lowest all-cause mortality in Q3, and the lowest cardiovascular mortality in Q4 (-value <0.0001). Cox regression analysis demonstrated significantly reduced risks of all-cause mortality (HR 0.64, 95 % CI 0.58, 0.73) and cardiovascular mortality (HR 0.58, 95 % CI 0.42, 0.82) in Q4 compared to Q1. RCS identified an L-shaped association between the HALP score and mortality, with inflection points at 42.29 (all-cause) and 39.98 (cardiovascular).

CONCLUSION

An L-shaped association between the HALP score and both all-cause and cardiovascular mortality in participants with diabetes mellitus or prediabetes.

摘要

目的

血红蛋白、白蛋白、淋巴细胞和血小板(HALP)评分与糖尿病/糖尿病前期患者死亡率之间的关系仍不明确。本研究旨在评估该人群中HALP评分与全因死亡率和心血管死亡率之间的线性和非线性关联,并确定潜在的临床相关阈值。

方法

我们使用两个关联数据集分析了19350名美国糖尿病/糖尿病前期成年人的数据:国家健康与营养检查调查(NHANES,2005 - 2018年)和国家死亡指数(NDI)的死亡率记录,随访至2019年12月31日。采用Kaplan-Meier生存曲线、Cox比例风险模型和受限立方样条(RCS)来评估HALP评分与死亡率的关联。

结果

Kaplan-Meier分析显示,第一四分位数(Q1)的全因死亡率最高,第三四分位数(Q3)的全因死亡率最低,第四四分位数(Q4)的心血管死亡率最低(P值<0.0001)。Cox回归分析表明,与Q1相比,Q4的全因死亡率(风险比[HR] 0.64,95%置信区间[CI] 0.58,0.73)和心血管死亡率(HR 0.58,95% CI 0.42,0.82)显著降低。RCS确定HALP评分与死亡率之间呈L形关联,全因死亡率的拐点为42.29,心血管死亡率的拐点为39.98。

结论

糖尿病或糖尿病前期参与者的HALP评分与全因死亡率和心血管死亡率之间呈L形关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccac/12136913/c6644d4973b9/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验